Debra Patt, MD, PhD, MBA, MPH, discusses how AI can streamline prior authorization and revenue cycle workflows in community ...

Advanced primary care may be one of employers' strongest tools for catching cancer earlier, and better support during and ...

The rapid expansion of cell and gene therapies and other very high-cost drugs may give value-based contracting a second life, ...

Objectives: To quantify community care consultations for patients with newly diagnosed diabetic foot ulcers (DFUs), identify associated patient- and facility-level chara ...

Yesterday, September 24, the FDA approved the combination of belzutifan (WELIREG; Merck) plus lenvatinib (LENVIMA; Eisai) to ...

Regulatory volatility since 2020, including IRA price negotiation, MFN pricing directives, and Medicaid best-price dynamics, ...

FDA movement of peptides toward 503A bulks listing advanced despite internal scientific objections citing absent human ...

Sophy Levine, PharmD, discusses how an integrated health system specialty pharmacy may help lower 1-year GLP-1 discontinuation.

Seshadri, MD, speaks on CLL's shift toward fixed-duration, MRD-guided regimens, MRD testing barriers, and open questions on ...

SHAP ranked age, BMI, and vaginal delivery count as dominant contributors, followed by systolic blood pressure, HbA1c, PIR, ...

Safety-net claims emphasize disproportionate Medicaid and uncompensated care borne by 340B hospitals, whereas other analyses ...

Community oncology practices face steep structural barriers to clinical trial enrollment, and pragmatic trial design that ...